$4972 | SAVE $678 | Single User
$5852 | SAVE $798 | Multi User
$7172 | SAVE $978 | Corporate License
$8800 | SAVE $1,200 | Enterprise License

Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021
[Report Updated: 27-03-2017]

Published by MarketsandMarkets: 27 Mar 2017 | 51220 | In Stock

Introduction

The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016, growing at a CAGR of 6.4% from 2016 to 2021. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes.

The topical drug delivery market is segmented based on product type, route of administration, facility of use, and regions. On the basis of route of administration, the market is segmented into skin, ophthalmic, rectal, vaginal, and nasal routes. Considering the high incidence of skin diseases, high demand for self-administration, and the increasing number of product approvals for skin-related drug delivery systems, the market for topical drugs administered through the skin is expected to register the highest CAGR during the forecast period.

Based on facility of use, the topical drug delivery market is categorized into hospitals and private clinics, health care settings, and other facilities of use such as research institutes and diagnostic centers. The hospitals and private clinics segment is expected to be the major end-user in the topical drug delivery market. This large share of this segment can is mainly attributed to the increasing incidence of skin diseases, the subsequent increase in the demand for topical products for the treatment of these diseases, increase in funding, and infrastructural development in hospitals.

Currently, North America dominates the topical drug delivery market, followed by Europe. However, the market in the Asia-Pacific is expected to witness the highest growth during the forecast period. The high growth in the Asia-Pacific market can be attributed to the rising geriatric population, increasing healthcare expenditure, rising disposable income, and growing focus of global pharmaceutical companies on the markets in emerging APAC countries.

Research Coverage:

This market is categorized on the basis of product type, route of administration, facilities of use, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of top players in the topical drug delivery market. The report analyzes the topical drug delivery market by product type, route of administration, facilities of use, and region.

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the topical drug delivery market.

• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the topical drug delivery market.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for topical drug delivery across geographies.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the topical drug delivery market.

Table of Contents
for Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021 [Report Updated: 27-03-2017]

  • TABLE OF CONTENTS

    1 INTRODUCTION 14

    1.1 OBJECTIVES OF THE STUDY 14

    1.2 MARKET DEFINITION 14

    1.3 MARKET SCOPE 15

    1.3.1 MARKETS COVERED 15

    1.3.2 YEARS CONSIDERED FOR THE STUDY 16

    1.4 CURRENCY 17

    1.5 LIMITATIONS 17

    1.6 STAKEHOLDERS 17

    2 RESEARCH METHODOLOGY 18

    2.1 MARKET SIZE ESTIMATION 20

    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22

    2.3 ASSUMPTIONS FOR THE STUDY 24

    3 EXECUTIVE SUMMARY 25

    4 PREMIUM INSIGHTS 28

    4.1 TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION 29

    4.2 TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE 30

    4.3 GEOGRAPHIC SNAPSHOT OF THE TOPICAL DRUG DELIVERY MARKET 31

    5 MARKET OVERVIEW 32

    5.1 INTRODUCTION 33

    5.2 MARKET DYNAMICS 33

    5.3 DRIVERS 34

    5.3.1 HIGH PREVALENCE OF SKIN DISEASES 34

    5.3.2 GROWING PREFERENCE FOR TOPICAL DRUG DELIVERY 34

    5.3.3 HIGH INCIDENCE OF BURN INJURIES 35

    5.3.4 RISING INCIDENCE OF DIABETES 35

    5.3.5 RISING GERIATRIC POPULATION 35

    5.4 RESTRAINTS 36

    5.4.1 NEGATIVE IMPACT OF PRODUCT RECALLS 36

    5.5 OPPORTUNITIES 36

    5.5.1 DELIVERY OF BIOLOGICS THROUGH THE TRANSDERMAL ROUTE 36

    5.5.2 ACQUISITION OF SMALL MARKET PLAYERS 37

    5.6 CHALLENGES 37

    5.6.1 LIMITED THERAPEUTIC AREAS OF TOPICAL DRUG DELIVERY 37

    6 TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE 38

    6.1 INTRODUCTION 39

    6.1.1 FORMULATIONS 40

    6.1.1.1 Liquid Topical Formulations 41

    6.1.1.1.1 Solutions 42

    6.1.1.1.2 Suspensions 43

    6.1.1.2 Semi-solid Topical Formulations 43

    6.1.1.2.1 Creams 45

    6.1.1.2.2 Gels 45

    6.1.1.2.3 Ointments 46

    6.1.1.2.4 Pastes 47

    6.1.1.2.5 Lotions 47

    6.1.1.3 Solid Topical Formulations 48

    6.1.1.3.1 Suppositories 49

    6.1.1.3.2 Powders 50

    6.1.2 DEVICES (TRANSDERMAL DRUG DELIVERY) 50

    6.1.2.1.1 Transdermal Patches 51

    6.1.2.1.2 Transdermal Gels 52

    7 TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION 53

    7.1 INTRODUCTION 54

    7.2 SKIN DRUG DELIVERY 55

    7.3 OPHTHALMIC DRUG DELIVERY 57

    7.4 RECTAL DRUG DELIVERY 59

    7.5 VAGINAL DRUG DELIVERY 59

    7.6 NASAL DRUG DELIVERY 60

    8 TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE 62

    8.1 INTRODUCTION 63

    8.2 HOSPITALS AND PRIVATE CLINICS 64

    8.3 HOME CARE SETTINGS 65

    8.4 OTHER FACILITIES OF USE 66

    9 TOPICAL DRUG DELIVERY MARKET, BY REGION 67

    9.1 INTRODUCTION 68

    9.2 NORTH AMERICA 68

    9.2.1 U.S. 71

    9.2.2 CANADA 73

    9.3 EUROPE 75

    9.3.1 GERMANY 78

    9.3.2 FRANCE 80

    9.3.3 U.K. 81

    9.3.4 REST OF EUROPE (ROE) 83

    9.4 ASIA-PACIFIC (APAC) 85

    9.4.1 JAPAN 89

    9.4.2 CHINA 90

    9.4.3 INDIA 92

    9.4.4 REST OF APAC 94

    9.5 REST OF THE WORLD 95

    10 COMPETITIVE LANDSCAPE 99

    10.1 OVERVIEW 99

    10.2 PLAYER RANKING 100

    10.3 COMPETITIVE SITUATION AND TRENDS 102

    10.3.1 PRODUCT LAUNCHES AND APPROVALS 102

    10.3.2 ACQUISITIONS 103

    10.3.3 AGREEMENTS & COLLABORATIONS 104

    10.3.4 EXPANSIONS 105

    11 COMPANY PROFILES 106

    (OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*

    11.1 GLAXOSMITHKLINE PLC 107

    11.2 JANSSEN GLOBAL SERVICES, LLC. (A SUBSIDIARY OF JOHNSON & JOHNSON) 110

    11.3 NOVARTIS AG 113

    11.4 GALDERMA S.A. 117

    11.5 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. 120

    11.6 BAYER AG 128

    11.7 3M DRUG DELIVERY SYSTEMS 130

    11.8 CRESCITA THERAPEUTICS INC. 132

    11.9 MEDPHARM 134

    11.10 CIPLA 135

    *Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

    12 APPENDIX 138

    12.1 INSIGHTS FROM INDUSTRY EXPERTS 138

    12.2 DISCUSSION GUIDE 139

    12.3 OTHER DEVELOPMENTS 141

    12.4 AVAILABLE CUSTOMIZATIONS 142

    12.5 RT: REAL-TIME MARKET INTELLIGENCE 142

    12.6 RELATED REPORTS 143

    12.7 AUTHOR DETAILS 144

List Of Tables
in Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021 [Report Updated: 27-03-2017]

LIST OF TABLES


TABLE 1 TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 39

TABLE 2 TOPICAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE,

2014–2021 (USD BILLION) 40

TABLE 3 TOPICAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION,

2014–2021 (USD BILLION) 41

TABLE 4 LIQUID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM,

2014–2021 (USD BILLION) 41

TABLE 5 LIQUID TOPICAL FORMULATIONS MARKET SIZE, BY REGION,

2014–2021 (USD BILLION) 42

TABLE 6 TOPICAL SOLUTIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 42

TABLE 7 TOPICAL SUSPENSIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 43

TABLE 8 SEMI-SOLID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM,

2014–2021 (USD BILLION) 44

TABLE 9 SEMI-SOLID TOPICAL FORMULATIONS MARKET SIZE, BY REGION,

2014–2021 (USD BILLION) 44

TABLE 10 TOPICAL CREAMS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 45

TABLE 11 TOPICAL GELS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 46

TABLE 12 TOPICAL OINTMENTS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 46

TABLE 13 TOPICAL PASTES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 47

TABLE 14 TOPICAL LOTIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 48

TABLE 15 SOLID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM,

2014–2021 (USD BILLION) 48

TABLE 16 SOLID TOPICAL FORMULATIONS MARKET SIZE, BY REGION,

2014–2021 (USD BILLION) 49

TABLE 17 TOPICAL SUPPOSITORIES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 49

TABLE 18 TOPICAL POWDERS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 50

TABLE 19 TRANSDERMAL DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014–2021 (USD BILLION) 51

TABLE 20 TRANSDERMAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION,

2014–2021 (USD BILLION) 51

TABLE 21 TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 52

TABLE 22 TRANSDERMAL GELS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 52

TABLE 23 TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION,

2014–2021 (USD BILLION) 54

TABLE 24 COMMERCIALLY AVAILABLE PRODUCTS 55

TABLE 25 SKIN DRUG DELIVERY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 56

TABLE 26 COMMERCIALLY AVAILABLE PRODUCTS 58

TABLE 27 OPHTHALMIC DRUG DELIVERY MARKET SIZE, BY REGION,

2014–2021 (USD BILLION) 58

TABLE 28 RECTAL DRUG DELIVERY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 59

TABLE 29 VAGINAL DRUG DELIVERY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 60

TABLE 30 COMMERCIALLY AVAILABLE PRODUCTS 61

TABLE 31 NASAL DRUG DELIVERY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 61

TABLE 32 GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 63

TABLE 33 TOPICAL DRUG DELIVERY MARKET SIZE FOR HOSPITALS AND PRIVATE CLINICS,

BY REGION, 2014–2021 (USD BILLION) 65

TABLE 34 TOPICAL DRUG DELIVERY MARKET SIZE FOR HOME CARE SETTINGS, BY REGION, 2014–2021 (USD BILLION) 66

TABLE 35 TOPICAL DRUG DELIVERY MARKET SIZE FOR OTHER FACILITIES OF USE,

BY REGION, 2014–2021 (USD BILLION) 66

TABLE 36 TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 68

TABLE 37 NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY,

2014-2021 (USD BILLION) 70

TABLE 38 NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2014–2021 (USD BILLION) 70

TABLE 39 NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 70

TABLE 40 NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014–2021 (USD BILLION) 71

TABLE 41 U.S.: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2014–2021 (USD BILLION) 72

TABLE 42 U.S.: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 72

TABLE 43 U.S.: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 73

TABLE 44 CANADA: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 74

TABLE 45 CANADA: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 74

TABLE 46 CANADA: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 75

TABLE 47 EUROPE: TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY,

2014–2021 (USD BILLION) 77

TABLE 48 EUROPE: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 77

TABLE 49 EUROPE: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 78

TABLE 50 EUROPE: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 78

TABLE 51 GERMANY: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 79

TABLE 52 GERMANY: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 79

TABLE 53 GERMANY: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 80

TABLE 54 FRANCE: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 80

TABLE 55 FRANCE: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 81

TABLE 56 FRANCE: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 81

TABLE 57 U.K.: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 82

TABLE 58 U.K.: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 82

TABLE 59 U.K.: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 83

TABLE 60 ROE: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 84

TABLE 61 ROE: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 84

TABLE 62 ROE: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 85

TABLE 63 ASIA-PACIFIC: TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY,

2014–2021 (USD BILLION) 87

TABLE 64 APAC: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 87

TABLE 65 APAC: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 88

TABLE 66 APAC: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 88

TABLE 67 JAPAN.: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 89

TABLE 68 JAPAN: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 89

TABLE 69 JAPAN: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 90

TABLE 70 CHINA.: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 90

TABLE 71 CHINA: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 91

TABLE 72 CHINA: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 91

TABLE 73 INDIA: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 92

TABLE 74 INDIA: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 93

TABLE 75 INDIA: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 93

TABLE 76 REST OF APAC: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2014–2021 (USD BILLION) 94

TABLE 77 REST OF APAC: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 94

TABLE 78 REST OF APAC: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014–2021 (USD BILLION) 95

TABLE 79 ROW: TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE,

2014–2021 (USD BILLION) 97

TABLE 80 ROW: TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014–2021 (USD BILLION) 97

TABLE 81 ROW: TOPICAL DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,

2014–2021 (USD BILLION) 98

TABLE 82 TOPICAL DRUG DELIVERY MARKET, BY KEY PLAYER, 2015 100

TABLE 83 PRODUCT LAUNCHES & APPROVALS, 2013–2017 103

TABLE 84 ACQUISITIONS, 2013–2017 103

TABLE 85 AGREEMENTS & COLLABORATIONS, 2013–2017 104

TABLE 86 EXPANSIONS, 2013–2017 105

TABLE 87 EXCHANGE RATE (UTILIZED FOR CONVERSION OF INR TO USD) 135

List Of Figures, Charts and Diagrams
in Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021 [Report Updated: 27-03-2017]

LIST OF FIGURES


FIGURE 1 RESEARCH DESIGN 18

FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 20

FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 21

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION 21

FIGURE 5 DATA TRIANGULATION METHODOLOGY 22

FIGURE 6 KEY DATA FROM SECONDARY SOURCES 23

FIGURE 7 KEY DATA FROM PRIMARY SOURCES 23

FIGURE 8 FORMULATIONS SEGMENT TO DOMINATE THE GLOBAL TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, DURING THE FORECAST PERIOD 25

FIGURE 9 HOSPITALS AND PRIVATE CLINICS TO HOLD LARGEST SHARE OF THE MARKET,

BY FACILITY OF USE, DURING THE FORECAST PERIOD 26

FIGURE 10 SKIN DRUG DELIVERY SEGMENT TO DOMINATE THE TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION 26

FIGURE 11 NORTH AMERICA EXPECTED TO HOLD THE LARGEST MARKET SHARE IN 2016, ASIA-PACIFIC TO WITNESS HIGHEST GROWTH 27

FIGURE 12 TOPICAL DRUG DELIVERY MARKET OVERVIEW INCREASING PREVALENCE OF SKIN DISEASES, THE KEY GROWTH DRIVER OF MARKET GROWTH 28

FIGURE 13 FORMULATIONS SEGMENT TO DOMINATE THE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT 28

FIGURE 14 SKIN TO COMMAND THE LARGEST SHARE OF THE ROUTE OF ADMINISTRATION MARKET IN 2016 29

FIGURE 15 SEMI-SOLID FORMULATIONS SEGMENT TO GROW AT THE HIGHEST CAGR IN THE TOPICAL DRUG DELIVERY FORMULATIONS MARKET 30

FIGURE 16 HOSPITALS AND PRIVATE CLINICS SEGMENT TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 30

FIGURE 17 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 31

FIGURE 18 TOPICAL DRUG DELIVERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES 33

FIGURE 19 FORMULATIONS TO COMMAND THE LARGEST SHARE OF THE TOPICAL DRUG DELIVERY MARKET IN 2016 39

FIGURE 20 TRANSDERMAL DRUG DELIVERY TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 54

FIGURE 21 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH IN THE SKIN DRUG DELIVERY MARKET 56

FIGURE 22 HOSPITALS AND PRIVATE CLINICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE TOPICAL DRUG DELIVERY MARKET IN 2016 63

FIGURE 23 APAC HOSPITALS AND PRIVATE CLINICS MARKET TO WITNESS HIGHEST GROWTH (2016 - 2021) 64

FIGURE 24 NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET SNAPSHOT 69

FIGURE 25 EUROPE: TOPICAL DRUG DELIVERY MARKET SNAPSHOT 76

FIGURE 26 APAC: TOPICAL DRUG DELIVERY MARKET SNAPSHOT 86

FIGURE 27 ROW: TOPICAL DRUG DELIVERY MARKET SNAPSHOT 96

FIGURE 28 KEY DEVELOPMENTS IN THE TOPICAL DRUG DELIVERY MARKET, 2013–2017 99

FIGURE 29 MARKET EVOLUTION FRAMEWORK 100

FIGURE 30 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES AND APPROVALS ACCOUNTED FOR THE LARGEST SHARE 102

FIGURE 31 GEOGRAPHIC REVENUE MIX OF THE TOP 5 PLAYERS IN THE TOPICAL DRUG DELIVERY MARKET 106

FIGURE 32 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2015) 107

FIGURE 33 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015) 110

FIGURE 34 NOVARTIS AG: COMPANY SNAPSHOT (2015) 113

FIGURE 35 NESTLÉ S.A.: COMPANY SNAPSHOT (2015) 117

FIGURE 36 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015) 120

FIGURE 37 BAYER AG.: COMPANY SNAPSHOT (2015) 128

FIGURE 38 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EUR TO USD) 129

FIGURE 39 3M: COMPANY SNAPSHOT (2015) 130

FIGURE 40 NUVO RESEARCH: COMPANY SNAPSHOT (2015) 132

FIGURE 41 CIPLA: COMPANY SNAPSHOT (2015) 135

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

51220 | MD 5119

Number of Pages

145

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! Global Topical Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts
Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical d...
01 Apr 2017 by Current Partnering USD $1,756 (normally
USD $1,995)
More Info
SAVE 12% today! Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Vials), Veterinary Vaccine Packaging (Livestock, Aquaculture, Porcine), Drug Delivery (Oral, Pulmonary, Topical), Raw Material (HDPE, LDPE), and Region - Global Forecast to 2021
“The pharmaceutical packaging market is projected to grow at a CAGR of 6.4% during forecast period, ...
09 Mar 2017 by MarketsandMarkets USD $6,292 (normally
USD $7,150)
More Info
SAVE 12% today! Global Topical Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts
Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical d...
01 Feb 2017 by Current Partnering USD $1,756 (normally
USD $1,995)
More Info
SAVE 12% today! Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021
The drug delivery technology market is projected to reach USD 1,669.40 billion by 2021 from USD 1,17...
12 Jan 2017 by MarketsandMarkets USD $4,972 (normally
USD $5,650)
More Info
SAVE 12% today! Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast to 2021
The global sugar excipients market is estimated to grow at a CAGR of 4.3% from 2016 to 2021, to reac...
08 Dec 2016 by MarketsandMarkets USD $4,972 (normally
USD $5,650)
More Info
SAVE 12% today! Global Topical Drug Delivery Partnering 2010-2016: Deal trends, players, financials and forecasts
Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical d...
01 Nov 2016 by Current Partnering USD $1,756 (normally
USD $1,995)
More Info
SAVE 12% today! Analgesics Market: By Type (Opioids, Non-Opioids) By Treatment Injection Route (Oral Injection, Intravenous Injection, Rectal Injection, Transdermal Injection, Topical Injection) & Geography-Forecast (2016-2021)
An analgesic or painkiller is a drug which is used to achieve analgesia, relief from pain. This type...
23 Feb 2016 by USD $4,620 (normally
USD $5,250)
More Info
SAVE 12% today! Animal Nutrition Market- By Nutrient (Amino Acids, Minerals, Vitamins, Eubiotics, Enzymes and Others); By Livestock (Ruminant, Poultry, Aquaculture, Swine, Equine, Pets); By Administration Method (Oral, Topical and Injection)- Forecast (2017 - 2022)
Nutrition is the basis of livestock production and proper nutrition is necessary for achievement of ...
14 Jan 2016 by USD $4,620 (normally
USD $5,250)
More Info
SAVE 12% today! Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Nasal (Drop), Topical (Solid), Implantable (Active), Transmucosal (Oral)), End User (Hospital, ASC, Home Care) -Forecast to 2020
The drug delivery technology market is expected to reach USD 1,504.7 billion by 2020 from USD 1,048....
05 Nov 2015 by MarketsandMarkets USD $4,972 (normally
USD $5,650)
More Info
SAVE 12% today! Sports Medicine Market by Product Type (Implants, Arthroscopy, Prosthetics, Orthobiologics, Braces, Topical Pain Relief, Thermal Therapy, Compression Clothing, Bandages & Tapes), by Application (Knee, Shoulder) - Analysis & Global Forecast to 2020
The sports medicine market comprises products and devices used by professional or non-professional a...
10 Sep 2015 by MarketsandMarkets USD $4,972 (normally
USD $5,650)
More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021 [Report Updated: 27-03-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...